Cholesterol PEG Maleimide Conjugate

<strong>Cholesterol PEG Maleimide Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2013209_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> Cholesterol PEG Maleimide, Cholesterol-PEG-Maleimide, Cholesterol-Maleimide_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hadinoto K, Sundaresan A, Cheow WS. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43._x000D_ 2: Cristóbal-Lecina E, Pulido D, Martin-Malpartida P, Macias MJ, Albericio F, Royo M. Synthesis of Stable Cholesteryl-Polyethylene Glycol-Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths ACS Omega. 2020 Mar 6;5(10):5508-5519._x000D_ 3: Powell D, Chandra S, Dodson K, Shaheen F, Wiltz K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer Eur J Pharm Biopharm. 2017 May;114:108-118._x000D_ 4: Nallamothu R, Wood GC, Kiani MF, Moore BM, Horton FP, Thoma LA. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies PDA J Pharm Sci Technol. 2006 May-Jun;60(3):144-55._x000D_ 5: Momtazi-Borojeni AA, Jaafari MR, Badiee A, Sahebkar A. Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system Atherosclerosis. 2019 Apr;283:69-78._x000D_ 6: Golkar N, Tamaddon AM, Samani SM. Effect of lipid composition on incorporation of trastuzumab-PEG-lipid into nanoliposomes by post-insertion method: physicochemical and cellular characterization J Liposome Res. 2016;26(2):113-25._x000D_ 7: Rivest V, Phivilay A, Julien C, Bélanger S, Tremblay C, Emond V, Calon F. Novel liposomal formulation for targeted gene delivery Pharm Res. 2007 May;24(5):981-90._x000D_ 8: Arab A, Behravan J, Razazan A, Gholizadeh Z, Nikpoor AR, Barati N, Mosaffa F, Badiee A, Jaafari MR. A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice J Drug Target. 2018 Apr;26(4):365-372._x000D_ 9: Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro Biochemistry. 1997 Jan 7;36(1):66-75._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/16796350">10: Nallamothu R, Wood GC, Pattillo CB, Scott RC, Kiani MF, Moore BM, Thoma LA. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation AAPS PharmSciTech. 2006 Apr 7;7(2):E32. </a>_x000D_ _x000D_ <strong>Products Related to Cholesterol PEG Maleimide Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Lipids/"> Lipids</a>